Skip Navigation

European Heart Journal 1999 20(16):1144-1145; doi:10.1053/euhj.1999.1719
Copyright © 1999 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ferrari, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ferrari, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorial

Metabolic treatment of myocardial ischaemia

R. Ferraria

a Editor, European Heart Journal Supplements

1999, 1999

References

  1. Boddeke E, Hugtenburg J, Jap W. New anti-ischaemic drugs: cytoprotective action with no primary haemodynamic effects. Trend Pharm Sci. 1981;10:340–397[CrossRef]
  2. Stanley WC, Lopaschuk CD, Nail JL. Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Cardiovasc Res. 1997;33:243–257[Free Full Text]
  3. Detry JM, Seiller P, Pennafortes. Trimetazidine: a new concept in the treatment of angina. Comparison with propanolol in patients with stable angina. Br J Clin Pharmacol. 1994;37:279–288[Web of Science][Medline]
  4. Manchanda SC, Krisimaswami S. Combination treatment with trimetazidine and diltiazem in stable angina pectoris. Heart. 1997;78:363–367
  5. Michaelides AP, Spiropoulos K, Dimopoules K. Antianginal efficacy of the combination of trimetazidine-propanolol compared with isosorbide dinitrate-propanolol in patients with stable angina. Clin Drug Invest. 1997;13:8–14

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Eur Heart J SupplHome page
R. Ferrari
Introduction
Eur. Heart J. Suppl., November 1, 2001; 3(suppl_O): O1 - O1.
[PDF]


This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ferrari, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ferrari, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?